Trader Repro Med Systems, Inc. - KRMD CFD
Ajouter aux favoris- Résumé
- Données historiques
- Événements
- Compte de résultat
- Bilan
- Flux de trésorerie
- Capital
Conditions de trading
| Écart | 0.08 | ||||||||
|
Frais de position longue en overnight
Long position overnight fee
Aller vers la plateforme | -0.025457% | ||||||||
|
Frais de position courte en overnight
Short position overnight fee
Aller vers la plateforme | 0.003235% | ||||||||
| Durée des frais en overnight | 21:00 (UTC) | ||||||||
| Quantité minimale négociée | 1 | ||||||||
| Devise | USD | ||||||||
| Marge | 20% | ||||||||
| Bourse | United States of America | ||||||||
| Commission sur la négociation | 0% |
*Information provided by Capital.com
KORU Medical Systems Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Chiffres clés
| Fermeture précédente* | 3.65 |
| Ouvert* | 3.65 |
| Variation sur 1 an* | 77.18% |
| Fourchette du jour* | 3.65 - 3.8 |
| Fourchette sur 52 semaines | 1.82-4.48 |
| Volume moyen (10 jours) | 44.58K |
| Volume moyen (3 mois) | 972.01K |
| Capitalisation boursière | 169.68M |
| Ratio C/B | -100.00K |
| Actions en circulation | 45.61M |
| Revenu | 29.04M |
| EPS | -0.19 |
| Dividende (rendement en %) | N/A |
| Bêta | 0.41 |
| Prochaine date de publication des résultats | N/A |
Toutes les données sont fournies par Refinitiv, à l'exception des données marquées d'un astérisque, qui sont des *données fournies par Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Clôture | Change | Change (%) | Ouverture | High | Low |
|---|---|---|---|---|---|---|
| Jun 1, 2023 | 3.65 | 0.06 | 1.67% | 3.59 | 3.67 | 3.58 |
| May 31, 2023 | 3.63 | 0.05 | 1.40% | 3.58 | 3.65 | 3.58 |
| May 30, 2023 | 3.63 | 0.02 | 0.55% | 3.61 | 3.72 | 3.60 |
| May 26, 2023 | 3.63 | 0.02 | 0.55% | 3.61 | 3.72 | 3.59 |
| May 25, 2023 | 3.62 | -0.02 | -0.55% | 3.64 | 3.68 | 3.59 |
| May 24, 2023 | 3.63 | 0.04 | 1.11% | 3.59 | 3.77 | 3.59 |
| May 23, 2023 | 3.70 | -0.07 | -1.86% | 3.77 | 3.81 | 3.69 |
| May 22, 2023 | 3.73 | -0.21 | -5.33% | 3.94 | 3.96 | 3.71 |
| May 19, 2023 | 3.96 | 0.16 | 4.21% | 3.80 | 3.96 | 3.69 |
| May 18, 2023 | 3.82 | -0.06 | -1.55% | 3.88 | 3.92 | 3.78 |
| May 17, 2023 | 3.94 | 0.15 | 3.96% | 3.79 | 3.94 | 3.78 |
| May 16, 2023 | 3.89 | -0.02 | -0.51% | 3.91 | 3.99 | 3.85 |
| May 15, 2023 | 3.94 | 0.14 | 3.68% | 3.80 | 3.94 | 3.78 |
| May 12, 2023 | 3.93 | 0.13 | 3.42% | 3.80 | 3.97 | 3.78 |
| May 11, 2023 | 3.92 | 0.12 | 3.16% | 3.80 | 3.98 | 3.80 |
| May 10, 2023 | 3.87 | 0.13 | 3.48% | 3.74 | 3.92 | 3.73 |
| May 9, 2023 | 3.77 | -0.06 | -1.57% | 3.83 | 3.87 | 3.69 |
| May 8, 2023 | 3.89 | 0.01 | 0.26% | 3.88 | 3.97 | 3.88 |
| May 5, 2023 | 3.95 | 0.02 | 0.51% | 3.93 | 4.01 | 3.91 |
| May 4, 2023 | 4.04 | 0.00 | 0.00% | 4.04 | 4.09 | 3.96 |
Repro Med Systems, Inc. Events
| Heure (UTC) (UTC) | Pays | Événement |
|---|---|---|
| Tuesday, August 1, 2023 | ||
| Heure (UTC) (UTC) 10:59 | Pays US
| Événement Q2 2023 KORU Medical Systems Inc Earnings Release Q2 2023 KORU Medical Systems Inc Earnings ReleaseForecast -Previous - |
| Tuesday, November 7, 2023 | ||
| Heure (UTC) (UTC) 10:59 | Pays US
| Événement Q3 2023 KORU Medical Systems Inc Earnings Release Q3 2023 KORU Medical Systems Inc Earnings ReleaseForecast -Previous - |
- Annuel
- Trimestriel
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Revenu total | 27.896 | 23.4902 | 24.1765 | 23.1626 | 17.3537 |
| Revenu | 27.896 | 23.4902 | 24.1765 | 23.1626 | 17.3537 |
| Coût des recettes, total | 12.5271 | 9.7206 | 9.24036 | 8.30881 | 6.54325 |
| Résultat brut | 15.369 | 13.7696 | 14.9361 | 14.8538 | 10.8105 |
| Total des frais d'exploitation | 38.6769 | 30.5197 | 25.4312 | 22.5769 | 16.1892 |
| Total des frais de vente/Généraux/Admin | 20.6065 | 17.8623 | 12.0283 | 9.77174 | 9.09557 |
| Recherche et développement | 4.95622 | 2.47367 | 1.29675 | 0.74048 | 0.24112 |
| Depreciation / Amortization | 0.58714 | 0.46313 | 0.4186 | 0.34023 | 0.30926 |
| Produits d'exploitation | -10.7809 | -7.02953 | -1.25478 | 0.58568 | 1.16454 |
| Produits (charges) d'intérêts, nets Hors exploitation | 0.10572 | -0.01583 | 0.04394 | 0.06291 | 0.00748 |
| Résultat net avant impôts | -10.6752 | -6.36444 | -1.19426 | 0.69642 | 1.17695 |
| Résultat net après impôts | -8.66114 | -4.56282 | -1.21206 | 0.56435 | 0.91057 |
| Résultat net avant éléments extra | -8.66114 | -4.56282 | -1.21206 | 0.56435 | 0.91057 |
| Résultat net | -8.66114 | -4.56282 | -1.21206 | 0.56435 | 0.91057 |
| Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | -8.66114 | -4.56282 | -1.21206 | 0.56435 | 0.91057 |
| Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | -8.66114 | -4.56282 | -1.21206 | 0.56435 | 0.91057 |
| Résultat net dilué | -8.66114 | -4.56282 | -1.21206 | 0.56435 | 0.91057 |
| Moyenne pondérée des actions diluées | 45.0021 | 44.385 | 41.9297 | 39.0613 | 38.9216 |
| BPA dilué hors éléments extraordinaires | -0.19246 | -0.1028 | -0.02891 | 0.01445 | 0.02339 |
| BPA dilué normalisé | -0.19246 | -0.10282 | 0.00877 | 0.08432 | 0.0233 |
| Total des éléments extraordinaires | |||||
| Dividends per Share - Common Stock Primary Issue | |||||
| Gain (Loss) on Sale of Assets | 0 | 0.00101 | 0.01659 | 0.04783 | 0.00493 |
| Charges (revenus) inhabituelles | 0 | 2.44721 | 3.41568 | ||
| Autres, nets | 0 | 0.67991 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Revenu total | 7.39261 | 7.34468 | 7.7604 | 6.54663 | 6.24433 |
| Revenu | 7.39261 | 7.34468 | 7.7604 | 6.54663 | 6.24433 |
| Coût des recettes, total | 3.24557 | 3.26654 | 3.43804 | 3.20046 | 2.62203 |
| Résultat brut | 4.14704 | 4.07814 | 4.32236 | 3.34617 | 3.6223 |
| Total des frais d'exploitation | 10.4494 | 9.8561 | 9.28988 | 10.1601 | 9.37085 |
| Total des frais de vente/Généraux/Admin | 5.42588 | 4.75992 | 4.82535 | 5.53002 | 5.49121 |
| Recherche et développement | 1.56487 | 1.64198 | 0.86215 | 1.30373 | 1.14836 |
| Depreciation / Amortization | 0.21312 | 0.18766 | 0.16434 | 0.12588 | 0.10925 |
| Produits d'exploitation | -3.05682 | -2.51142 | -1.52948 | -3.61346 | -3.12652 |
| Produits (charges) d'intérêts, nets Hors exploitation | 0.12482 | 0.10003 | 0.03242 | -0.01814 | -0.0086 |
| Gain (Loss) on Sale of Assets | -0.05628 | 0 | 0 | 0 | 0 |
| Résultat net avant impôts | -2.98829 | -2.41139 | -1.49706 | -3.6316 | -3.13511 |
| Résultat net après impôts | -2.41089 | -1.97673 | -1.22556 | -2.92134 | -2.53751 |
| Résultat net avant éléments extra | -2.41089 | -1.97673 | -1.22556 | -2.92134 | -2.53751 |
| Résultat net | -2.41089 | -1.97673 | -1.22556 | -2.92134 | -2.53751 |
| Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | -2.41089 | -1.97673 | -1.22556 | -2.92134 | -2.53751 |
| Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | -2.41089 | -1.97673 | -1.22556 | -2.92134 | -2.53751 |
| Résultat net dilué | -2.41089 | -1.97673 | -1.22556 | -2.92134 | -2.53751 |
| Moyenne pondérée des actions diluées | 45.4876 | 45.3762 | 45.0382 | 44.9219 | 44.668 |
| BPA dilué hors éléments extraordinaires | -0.053 | -0.04356 | -0.02721 | -0.06503 | -0.05681 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| BPA dilué normalisé | -0.0522 | -0.04356 | -0.02721 | -0.06503 | -0.05681 |
| Charges (revenus) inhabituelles | |||||
| Autres, nets |
- Annuel
- Trimestriel
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total de l'actif à court terme | 29.8016 | 37.3212 | 37.5258 | 11.8813 | 9.03305 |
| Espèces et placements à court terme | 17.4083 | 25.3349 | 27.3153 | 5.87093 | 5.25673 |
| Trésorerie et équivalents | 17.4083 | 25.3349 | 27.3153 | 5.87093 | 3.7388 |
| Investissements à court terme | 0 | 1.51793 | |||
| Total des créances, nettes | 4.53128 | 4.31111 | 2.57295 | 3.23452 | 1.42585 |
| Accounts Receivable - Trade, Net | 3.55888 | 3.59289 | 2.57295 | 3.23452 | 1.42585 |
| Total Inventory | 6.40487 | 6.10634 | 6.82977 | 2.38848 | 2.10388 |
| Prepaid Expenses | 1.45723 | 1.56882 | 0.80778 | 0.3874 | 0.24659 |
| Total Assets | 42.3324 | 41.293 | 39.9189 | 13.8819 | 10.545 |
| Property/Plant/Equipment, Total - Net | 7.67352 | 1.202 | 1.40447 | 0.98558 | 0.85878 |
| Intangibles, Net | 0.78718 | 0.80881 | 0.84359 | 0.80714 | 0.63216 |
| Other Long Term Assets, Total | 4.07011 | 1.96107 | 0.14509 | 0.20782 | 0.02105 |
| Total Current Liabilities | 6.95894 | 4.79198 | 3.6664 | 2.40629 | 1.58423 |
| Accounts Payable | 2.3918 | 1.22753 | 0.62492 | 0.57266 | 0.4535 |
| Accrued Expenses | 3.77817 | 2.96586 | 3.03884 | 1.82834 | 1.12697 |
| Notes Payable/Short Term Debt | 0.4333 | 0.50858 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 0.25734 | 0.09 | 0 | 0.00376 | |
| Total Liabilities | 11.0065 | 4.79198 | 3.76196 | 2.64578 | 1.58423 |
| Total Long Term Debt | 0.39428 | 0 | 0 | 0.00265 | 0 |
| Deferred Income Tax | 0 | ||||
| Other Liabilities, Total | 3.65326 | 0 | 0.09555 | 0.23685 | 0 |
| Total Equity | 31.326 | 36.5011 | 36.157 | 11.2361 | 8.96081 |
| Common Stock | 0.48862 | 0.48044 | 0.4668 | 0.4224 | 0.40933 |
| Additional Paid-In Capital | 44.2521 | 40.7743 | 35.881 | 6.29307 | 4.59521 |
| Retained Earnings (Accumulated Deficit) | -9.57121 | -0.91007 | 3.65275 | 4.86482 | 4.30047 |
| Treasury Stock - Common | -3.84356 | -3.84356 | -3.84356 | -0.3442 | -0.3442 |
| Total Liabilities & Shareholders’ Equity | 42.3324 | 41.293 | 39.9189 | 13.8819 | 10.545 |
| Total Common Shares Outstanding | 45.4414 | 44.6237 | 43.2596 | 39.5026 | 38.1957 |
| Property/Plant/Equipment, Total - Gross | 10.4679 | 3.51403 | 3.39009 | 2.80482 | |
| Accumulated Depreciation, Total | -2.7944 | -2.31203 | -1.98562 | -1.81924 | |
| Current Port. of LT Debt/Capital Leases | 0.09834 | 0 | 0.00265 | 0.0053 | |
| Capital Lease Obligations | 0.39428 | 0 | 0.00265 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total de l'actif à court terme | 25.2147 | 29.8016 | 30.7423 | 30.9683 | 33.9313 |
| Espèces et placements à court terme | 12.2249 | 17.4083 | 16.4413 | 18.2656 | 22.5772 |
| Trésorerie et équivalents | 12.2249 | 17.4083 | 16.4413 | 18.2656 | 22.5772 |
| Total des créances, nettes | 5.17927 | 4.53128 | 5.75619 | 4.76556 | 3.82547 |
| Accounts Receivable - Trade, Net | 4.16451 | 3.55888 | 5.07008 | 4.08476 | 3.1454 |
| Total Inventory | 6.63842 | 6.40487 | 6.88416 | 6.77151 | 6.01774 |
| Prepaid Expenses | 1.1721 | 1.45723 | 1.66066 | 1.16567 | 1.51085 |
| Total Assets | 38.254 | 42.3324 | 42.6658 | 42.4613 | 43.4276 |
| Property/Plant/Equipment, Total - Net | 7.61294 | 7.67352 | 7.51538 | 7.36317 | 6.07255 |
| Property/Plant/Equipment, Total - Gross | 9.8376 | 10.4679 | 10.166 | 9.86705 | 8.46595 |
| Accumulated Depreciation, Total | -2.22466 | -2.7944 | -2.65064 | -2.50387 | -2.39339 |
| Intangibles, Net | 0.78253 | 0.78718 | 0.79853 | 0.79178 | 0.79534 |
| Other Long Term Assets, Total | 4.64385 | 4.07011 | 3.6096 | 3.3381 | 2.62844 |
| Total Current Liabilities | 4.52422 | 6.95894 | 6.16749 | 5.73013 | 4.71262 |
| Accounts Payable | 1.50312 | 2.3918 | 1.36561 | 2.38986 | 1.26798 |
| Accrued Expenses | 2.44146 | 3.77817 | 3.73519 | 3.03327 | 3.0734 |
| Notes Payable/Short Term Debt | 0.2184 | 0.4333 | 0.64473 | 0 | 0.25561 |
| Current Port. of LT Debt/Capital Leases | 0.09969 | 0.09834 | 0.06447 | 0.0665 | |
| Total Liabilities | 8.45768 | 11.0065 | 10.1741 | 9.83999 | 8.62654 |
| Total Long Term Debt | 0.36884 | 0.39428 | 0.26554 | 0.28196 | 0 |
| Other Liabilities, Total | 3.56462 | 3.65326 | 3.74102 | 3.8279 | 3.91392 |
| Total Equity | 29.7963 | 31.326 | 32.4917 | 32.6213 | 34.8011 |
| Common Stock | 0.48961 | 0.48862 | 0.48657 | 0.48408 | 0.48121 |
| Additional Paid-In Capital | 45.1324 | 44.2521 | 43.4432 | 42.3498 | 41.611 |
| Retained Earnings (Accumulated Deficit) | -11.9821 | -9.57121 | -7.59448 | -6.36892 | -3.44758 |
| Treasury Stock - Common | -3.84356 | -3.84356 | -3.84356 | -3.84356 | -3.84356 |
| Total Liabilities & Shareholders’ Equity | 38.254 | 42.3324 | 42.6658 | 42.4613 | 43.4276 |
| Total Common Shares Outstanding | 45.5403 | 45.4414 | 45.2365 | 44.9871 | 44.7008 |
| Other Current Liabilities, Total | 0.26154 | 0.25734 | 0.35749 | 0.2405 | 0.11563 |
| Capital Lease Obligations | 0.36884 | 0.39428 | 0.26554 | 0.28196 |
- Annuel
- Trimestriel
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Revenu net/Ligne de départ | -8.66114 | -4.56282 | -1.21206 | 0.56435 | 0.91057 |
| Liquidités provenant des activités d'exploitation | -5.40455 | -4.31951 | -0.74332 | 0.32062 | 1.47966 |
| Liquidités provenant des activités d'exploitation | 0.58714 | 0.46313 | 0.4186 | 0.34023 | 0.30926 |
| Deferred Taxes | -2.02623 | -1.81598 | 0.06297 | -0.18678 | -0.02314 |
| Éléments non monétaires | 3.29197 | 2.70655 | 2.92099 | 1.1484 | 0.2991 |
| Cash Taxes Paid | 0 | 0.0019 | 0.32198 | 0.13088 | 0.378 |
| Intérêts payés en espèces | 0.02849 | 0.01324 | 0.02774 | 0.00034 | 0 |
| Variation du fonds de roulement | 1.40371 | -1.11038 | -2.93381 | -1.54558 | -0.01613 |
| Flux de trésorerie liés aux activités d'investissement | -2.80157 | -0.36617 | -1.03615 | 1.31021 | -1.72982 |
| Dépenses d'investissement | -2.80157 | -0.37523 | -1.06115 | -0.42554 | -0.48117 |
| Autres éléments de flux de trésorerie d'investissement, total | 0 | 0.00907 | 0.025 | 1.73575 | -1.24866 |
| Flux de trésorerie provenant des activités de financement | 0.27949 | 2.70528 | 23.2238 | 0.5013 | 0.01443 |
| Éléments de flux de trésorerie de financement | -0.07529 | 0.50858 | 0 | -0.00282 | -0.03682 |
| Émission (remboursement) d'actions, nette | 0.40662 | 2.19935 | 23.2291 | 0.5089 | 0.05125 |
| Variation nette de la trésorerie | -7.92663 | -1.9804 | 21.4444 | 2.13213 | -0.23573 |
| Émission (remboursement) de la dette, nette | -0.05185 | -0.00265 | -0.0053 | -0.00478 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -2.41089 | -8.66114 | -6.68442 | -5.45886 | -2.53751 |
| Cash From Operating Activities | -4.66058 | -5.40455 | -6.74101 | -4.62531 | -1.75207 |
| Cash From Operating Activities | 0.21312 | 0.58714 | 0.39948 | 0.23513 | 0.10925 |
| Deferred Taxes | -0.5774 | -2.02623 | -1.57957 | -1.30807 | -0.5976 |
| Non-Cash Items | 0.932 | 3.29197 | 2.57913 | 1.57915 | 0.83756 |
| Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
| Cash Interest Paid | 0.01233 | 0.02849 | 0.0157 | 0.0062 | 0.00443 |
| Changes in Working Capital | -2.81742 | 1.40371 | -1.45564 | 0.32733 | 0.43623 |
| Cash From Investing Activities | -0.28384 | -2.80157 | -2.5777 | -1.92883 | -0.7526 |
| Capital Expenditures | -0.28384 | -2.80157 | -2.5777 | -1.92883 | -0.7526 |
| Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
| Cash From Financing Activities | -0.23897 | 0.27949 | 0.42509 | -0.51519 | -0.25297 |
| Issuance (Retirement) of Stock, Net | 0.40662 | 0.314 | 0 | 0 | |
| Issuance (Retirement) of Debt, Net | -0.02408 | -0.05185 | -0.02506 | -0.00661 | 0 |
| Net Change in Cash | -5.18339 | -7.92663 | -8.89362 | -7.06934 | -2.75764 |
| Financing Cash Flow Items | -0.21489 | -0.07529 | 0.13615 | -0.50858 | -0.25297 |
| Nom de l'investisseur | Catégorie de l'investisseur | Pourcentage de l'encours | Actions détenues | Changement d'actions | Date d'avoirs | Taux du chiffre d'affaires |
|---|---|---|---|---|---|---|
| Horton Capital Management LLC | Hedge Fund | 21.4308 | 9775261 | -876758 | 2023-02-24 | LOW |
| First Light Asset Management, LLC | Investment Advisor/Hedge Fund | 13.5735 | 6191317 | -146765 | 2023-03-31 | LOW |
| Archon Capital Management LLC | Hedge Fund | 6.5107 | 2969732 | 0 | 2023-03-31 | |
| Frommer (Kathy S) | Individual Investor | 3.804 | 1735139 | 5221 | 2022-03-31 | |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.7124 | 1693342 | 346760 | 2023-03-31 | LOW |
| Tharby (Linda M) | Individual Investor | 3.4012 | 1551404 | 1187132 | 2023-03-24 | |
| Parkman Healthcare Partners LLC | Hedge Fund | 1.8665 | 851375 | 128319 | 2023-03-31 | HIGH |
| Albion Financial Group | Investment Advisor/Hedge Fund | 1.8095 | 825361 | -51091 | 2023-03-31 | LOW |
| B. Riley Asset Management, LLC | Investment Advisor/Hedge Fund | 1.7341 | 790990 | -113035 | 2023-03-31 | HIGH |
| Altium Capital Management LP | Investment Advisor/Hedge Fund | 1.5018 | 685002 | -169998 | 2023-03-31 | LOW |
| Goldberger (Daniel S) | Individual Investor | 1.2504 | 570334 | 105221 | 2022-03-31 | LOW |
| Meros Investment Management, LP | Investment Advisor | 0.9375 | 427642 | -5204 | 2023-03-31 | MED |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.7446 | 339628 | 459 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7432 | 339015 | 0 | 2023-03-31 | LOW |
| Boothbay Fund Management, LLC | Investment Advisor/Hedge Fund | 0.6945 | 316791 | 14354 | 2023-03-31 | HIGH |
| Beck (James M.) | Individual Investor | 0.5015 | 228744 | -5793 | 2023-03-31 | LOW |
| KeyBanc Capital Markets | Research Firm | 0.474 | 216224 | 0 | 2023-03-31 | LOW |
| Millennium Management LLC | Hedge Fund | 0.2986 | 136223 | 136223 | 2023-03-31 | HIGH |
| Empire Financial Management Company, LLC | Investment Advisor | 0.296 | 135000 | 135000 | 2023-03-31 | |
| HighMark Wealth Management LLC | Investment Advisor | 0.2651 | 120935 | 0 | 2023-03-31 | LOW |
Pourquoi choisir capital.com? Nos chiffres parlent d'eux-mêmes.
Capital.com Group535K+
Tradeurs
87K+
Clients actifs par mois
$113M+
Volume d'investissement par mois
$64M+
Retrait par mois
Trading calculator
Calculez votre P&L hypothétique si vous aviez ouvert une transaction CFD à une certaine date (sélectionnez une date) et l'aviez fermée à une autre date (sélectionnez une date).
Trade commission
0
- 1:1
Effet de levier
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Ouverture
Clôture
Short Long
Repro Med Systems, Inc. Company profile
À propos de Repro Med Systems, Inc.
Repro Med Systems, Inc. est une société de technologie médicale qui se concentre sur le développement, la fabrication et la commercialisation de solutions de perfusion spécialisées. La société conçoit, fabrique et commercialise des dispositifs médicaux, principalement pour le marché de la perfusion ambulatoire. Son développement et sa commercialisation se concentrent principalement sur ses produits de perfusion mécanique. Les produits de la société comprennent les systèmes de perfusion FREEDOM, qui consistent en un pousse-seringue FREEDOM60, un pousse-seringue FreedomEdge, des jeux d'aiguilles de sécurité sous-cutanées HIgHFlo et des tubes à débit précis. Le système FREEDOM fonctionne à une pression plus faible et maintient un équilibre entre ce que les tissus sous-cutanés d'un patient peuvent absorber et ce que le système délivre. La société réalise l'assemblage des produits, l'étalonnage, l'inspection et les tests de contrôle de la qualité avant et après l'assemblage, ainsi que l'emballage final de tous ses produits sur son site de Chester, dans l'État de New York.
100 Corporate Drive
MAHWAH
NEW JERSEY 07430
US
Compte de résultat
- Annual
- Quarterly
Les gens regardent aussi
Êtes-vous toujours à la recherche d'un broker de confiance?
Rejoignez les plus de 535 000 traders du monde entier qui ont choisi de trader avec Capital.com